Trial intelligence / Profile preview

Ticagrelor vs Clopidogrel in NSTE-ACS Endothelial Dysfunction

NCT02379676Phase 4Unknown

Start
Jan 2015
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ticagrelor in endothelial dysfunction, vasculitis. Status: unknown.

02

Drugs

ticagrelor
03

Conditions

endothelial dysfunctionvasculitis

Beyond the preview

Go deeper on NCT02379676.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02379676.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call